Samantha Gao-Sheridan

Senior Director, Regulatory Affairs Cmc @Alnylam Pharmaceuticals

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2015 — Present

Senior Director, Regulatory Affairs Cmc @Alnylam Pharmaceuticals

View department →

Head regulatory affairs CMC function. Develop, shape, and establish RA CMC as a key partner to internal and external stakeholders by delivering robust global regulatory CMC strategy and compliance, and making positive contribution and impact on meeting company objectives and milestones.

EDUCATION

N/A

Peking Union Medical College (PUMC)

Medicine

N/A

Harvard Medical School

Postdoctoral Fellow, Bacterial Pathogenesis (Anthrax Toxin)

N/A

Rutgers University

Master of Science - MS, Toxicology

N/A

UC Irvine

PhD, Biochemistry and Molecular Biology

SKILLS

Monoclonal AntibodiesVaccinesDrug DevelopmentBiopharmaceuticalsRegulatory SubmissionsQuality by DesignTechnology TransferClinical TrialsClinical ResearchIndRegulatory AffairsBiotechnologyPharmaceutical IndustryProtein ChemistryCmcClinical Development

ABOUT SAMANTHA GAO-SHERIDAN

Vice President, Global Regulatory Affairs CMC, PTC Therapeutics

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Samantha Gao-Sheridan — Senior Director, Regulatory Affairs Cmc at Alnylam Pharmaceuticals in Cambridge, MA, US | Unifers